Think “Lower Is Better” for LDL in Patients at High CV Risk
Debate continues about whether to aim for a specific LDL goal.
For over a decade, the focus has been on using target DOSES of statins shown to reduce CV risk...rather than titrating to an LDL goal.
But there’s been a shift toward a blended approach in recent years.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote